返回 Agenda
Session Chair(s)
Representative Invited
WHO, India
Speaker(s)
Oversea GMP Inspection by CFDA: Current Status and Future Outcome
Representative Invited
China
Comprehensive Quality Evaluation of Drugs Made in China ~ Chinese version only
Bo Wang
the Research Center of National Drug Policy and Ecosystem(NDPE), China